PAR-21-054 - Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 4
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases | NOT-AR-22-012 | NIAMS | Dec 28, 2021 | Jan 8, 2023 | R21, R01 |
Notice of Special Interest (NOSI): Promoting Pain Research Within the NIAMS Mission Areas | NOT-AR-22-007 | NIAMS | Sep 23, 2021 | Jan 10, 2023 | R01, R21, R15, R33, R13, R34, K99/R00, K24, K01, K25, K23, K08, 332 |
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases | NOT-AR-21-012 | NIAMS | Jan 5, 2021 | Nov 19, 2021 | R01, R21 |
Notice of Special Interest: Promoting research opportunities on HIV/AIDS in NIAMS | NOT-AR-20-005 | NIAMS | Oct 22, 2019 | Jan 10, 2023 | R01, R21, 333 |